That extended waiting period could be tough on Anthem and Cigna's strategy and planning efforts. But here's something notable: The two firms are already having a rough ride on Wall Street.

Cigna’s mean price target of $377.80 represents a 25.1% premium to current price levels, and its Street-high target of $407 indicates a 34.8% upside potential.

Cigna and Humana are in talks to merge, according to the Wall Street Journal. The two health insurers are discussing a stock-and-cash deal that could be finalized by the end of this year, WSJ ...

Cigna closed out 2024 on shaky footing, posting fourth-quarter results below Wall Street’s expectations due to a rise in medical costs. Julia Rendleman via Getty Images Listen to the article 9 min ...

The average brokerage recommendation (ABR) for Cigna (CI) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after ...

If Humana and Cigna had combined, the new company could have been valued at roughly $135 billion, according to the Wall Street Journal. Cigna is an industry leader in commercial health insurance ...

Cigna, Humana in talks to combine in stock-and-cash deal - WSJ. ... Wall Street's major averages on Wednesday ended mixed. The Nasdaq shed 0.16%. The S&P 500 ...

A health insurance megamerger is reportedly brewing. The Wall Street Journal, citing people familiar with the matter, reported on Wednesday that payer giants Cigna and Humana are exploring a ...

Cigna’s mean price target of $377.80 represents a 25.1% premium to current price levels, and its Street-high target of $407 indicates a 34.8% upside potential.